Ghent University Academic Bibliography

Advanced

Malignant pleural mesothelioma: the standard of care and challenges for future management

Jan Van Meerbeeck UGent, Arnaud Scherpereel, Veerle Surmont UGent and Paul Baas (2011) CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 78(2). p.92-111
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (review)
publication status
published
subject
keyword
Cancer, Mesothelioma, Pleura, Chemotherapy, Surgery, Radiotherapy, Palliation, Supportive care, Pleurodesis, PHASE-II TRIAL, MODULATED RADIATION-THERAPY, HISTONE DEACETYLASE INHIBITORS, PEMETREXED PLUS CARBOPLATIN, DOSE HEMITHORACIC RADIATION, RANDOMIZED CONTROLLED-TRIAL, ENDOTHELIAL GROWTH-FACTOR, EXTRAPLEURAL PNEUMONECTOMY, LUNG-CANCER, EUROPEAN-ORGANIZATION, Guidelines, Treatment
journal title
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Crit. Rev. Oncol./Hematol.
volume
78
issue
2
pages
92 - 111
Web of Science type
Review
Web of Science id
000290076000002
JCR category
ONCOLOGY
JCR impact factor
4.411 (2011)
JCR rank
37/190 (2011)
JCR quartile
1 (2011)
ISSN
1040-8428
DOI
10.1016/j.critrevonc.2010.04.004
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
2026914
handle
http://hdl.handle.net/1854/LU-2026914
date created
2012-02-10 12:16:52
date last changed
2012-02-15 16:48:27
@article{2026914,
  author       = {Van Meerbeeck, Jan and Scherpereel, Arnaud and Surmont, Veerle and Baas, Paul},
  issn         = {1040-8428},
  journal      = {CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY},
  keyword      = {Cancer,Mesothelioma,Pleura,Chemotherapy,Surgery,Radiotherapy,Palliation,Supportive care,Pleurodesis,PHASE-II TRIAL,MODULATED RADIATION-THERAPY,HISTONE DEACETYLASE INHIBITORS,PEMETREXED PLUS CARBOPLATIN,DOSE HEMITHORACIC RADIATION,RANDOMIZED CONTROLLED-TRIAL,ENDOTHELIAL GROWTH-FACTOR,EXTRAPLEURAL PNEUMONECTOMY,LUNG-CANCER,EUROPEAN-ORGANIZATION,Guidelines,Treatment},
  language     = {eng},
  number       = {2},
  pages        = {92--111},
  title        = {Malignant pleural mesothelioma: the standard of care and challenges for future management},
  url          = {http://dx.doi.org/10.1016/j.critrevonc.2010.04.004},
  volume       = {78},
  year         = {2011},
}

Chicago
Van Meerbeeck, Jan, Arnaud Scherpereel, VEERLE SURMONT, and Paul Baas. 2011. “Malignant Pleural Mesothelioma: The Standard of Care and Challenges for Future Management.” Critical Reviews in Oncology Hematology 78 (2): 92–111.
APA
Van Meerbeeck, J., Scherpereel, A., SURMONT, V., & Baas, P. (2011). Malignant pleural mesothelioma: the standard of care and challenges for future management. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 78(2), 92–111.
Vancouver
1.
Van Meerbeeck J, Scherpereel A, SURMONT V, Baas P. Malignant pleural mesothelioma: the standard of care and challenges for future management. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2011;78(2):92–111.
MLA
Van Meerbeeck, Jan, Arnaud Scherpereel, VEERLE SURMONT, et al. “Malignant Pleural Mesothelioma: The Standard of Care and Challenges for Future Management.” CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 78.2 (2011): 92–111. Print.